Login or Subscribe [/membership][membership level=”1,5,6,7,8,9,10,11,12″][membership]
FDA published the 2017 annual report on facility inspection data related to drug and device approvals as mandated under FDA- RA. Data on human drugs is summarized in five tables and contains information, such as: ● the median time between the begin- ning of inspections and the issuance of an FDA 483, and ● the median time between 483 issuance to the regulatory or enforcement action.
[/membership]